Benzodiazepines vs. Cyclobenzaprine
Title: Benzodiazepines vs. CyclobenzaprineCategory: MedicationsCreated: 8/20/2018 12:00:00 AMLast Editorial Review: 8/20/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 20, 2018 Category: Drugs & Pharmacology Source Type: news
Flexeril (Cyclobenzaprine Hcl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 10, 2017 Category: Drugs & Pharmacology Source Type: news
What WellCare did about the opioid epidemic before Trump declared a public health emergency
Months before President Donald Trump declared the opioid epidemic a national public health emergency, WellCare Health Plans Inc. was tackling the issue.
A pilot program by the Tampa-based managed health care company cut opioid dispensing by about 50 percent in Kentucky, which has one of the highest rates of opioid abuse and overdose deaths in the nation, a press release said.
The pilot program a lso reduced dispensing of cyclobenzaprine, a common muscle relaxant, by 35 percent, and reduced dispensing… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 27, 2017 Category: American Health Authors: Margie Manning Source Type: news
Apace Packaging LLC Issues Voluntary Nationwide Recall of Cyclobenzaprine HCL and Amantadine HCL (Lot 16710) Due to Potential Mislabeling
Apace Packaging LLC is voluntarily recalling one lot of Cyclobenzaprine HCl Tablet, USP 5 mg 50ct Unit Dose, NDC# 50268-190-15, Lot Number 16710 and one lot of Amantadine HCl Capsule, USP 100 mg 50ct Unit Dose NDC# 50268-069-15, Lot Number 16710 to the Retail level. These products have been recalled due to a potential mislabeling. A small number of cartons containing Cyclobenzaprine HCl Tablets 5 mg UD Blister Cards may potentially be mislabeled as Amantadine HCl Capsules, USP 100 mg. The unit dose blisters inside the carton are correctly labeled as Cyclobenzaprine HCl Tablet, USP 5 mg. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 27, 2017 Category: Food Science Source Type: news
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya as Proposed Brand Name for TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) for the Treatment of PTSD
NEW YORK, July 06, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix) a company that is developing innovative pharmaceutical products to address public health challenges today reported that the U.S. Food and Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - July 6, 2017 Category: Drugs & Pharmacology Source Type: news
Tonix Pharmaceuticals PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation by the FDA
Responding to AtEase study results in military-related PTSD population, FDA agrees to work closely with Tonix to develop and review TNX-102 SL for PTSD as efficiently as possible
NEW YORK, Dec. 19, 2016 -- (Healthcare Sales & Marketing Network) -- Tonix... Biopharmaceuticals, FDA Tonix Pharmaceuticals, TNX-102 SL, cyclobenzaprine, PTSD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 19, 2016 Category: Pharmaceuticals Source Type: news
cyclobenzaprine (Flexeril, Amrix, Fexmid)
Title: cyclobenzaprine (Flexeril, Amrix, Fexmid)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/11/2016 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - November 11, 2016 Category: Anesthesiology Source Type: news
Product Catalogue by Adare Pharmaceuticals
Adare Pharma's Products include Potassium Chloride Microcaps Exended-Release tablets at strengths of 20mEq, 10 mEq/8mEq, marketed in the US and Canada, and
Cyclobenzaprine Diffucaps Extended-Release/Amrix capsules at strengths of 15mg and 30mg, mark … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2016 Category: Pharmaceuticals Source Type: news
Sublingual cyclobenzaprine may be effective, safe for military-related PTSD
SCOTTSDALE, ARIZ. – A sublingual formulation of cyclobenzaprine taken at bedtime was significantly better than placebo at reducing symptoms of military-related posttraumatic stress disorder, and... (Source: Family Practice News)
Source: Family Practice News - July 30, 2016 Category: Primary Care Source Type: news
Tonix reports positive results from Phase ll trial of TNX-102 SL to treat PTSD
Tonix Pharmaceuticals has reported positive results from a Phase ll, dose-finding clinical trial of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) to treat military-related post-traumatic stress disorder (PTSD). (Source: Drug Development Technology)
Source: Drug Development Technology - May 30, 2016 Category: Pharmaceuticals Source Type: news
Tonix reports positive results from Phase ll trial of TNX-102 SL to treat PTSD
Tonix Pharmaceuticals has reported positive results from a Phase ll, dose-finding clinical trial of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) in military-related post-traumatic stress disorder (PTSD), AtEase study. (Source: Drug Development Technology)
Source: Drug Development Technology - May 22, 2016 Category: Pharmaceuticals Source Type: news
Positive Topline Results for Military-Related PTSD DrugPositive Topline Results for Military-Related PTSD Drug
Reformulated cyclobenzaprine taken sublingually at bedtime appears to significantly reduce military-related PTSD symptoms, a phase 2 study shows. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 19, 2016 Category: Psychiatry Tags: Psychiatry News Source Type: news
cyclobenzaprine, Flexeril, Amrix, Fexmid
Title: cyclobenzaprine, Flexeril, Amrix, FexmidCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/29/2016 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - March 29, 2016 Category: Anesthesiology Source Type: news
Dual Therapy No Better Than NSAIDs Alone for Low Back Pain Dual Therapy No Better Than NSAIDs Alone for Low Back Pain
In patients with acute nontraumatic lower back pain, adding cyclobenzaprine or oxycodone/acetaminophen to naproxen alone did not improve functional outcomes or pain at 1 week. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 22, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
